Investors

Expedeon Introduces Lightning-Link Rapid Bioconjugation Kits

New kits enable customers to conjugate primary antibodies in 20 minutes

Cambridge, UK, 3rd November 2014: Expedeon (Innova), a specialist provider of bioconjugation products and services, announced today the launch of new antibody and protein labelling kits within its Lightning-Link® Rapid range. These kits enable researchers to label primary antibodies or other proteins in just 20 minutes.

Dyes recently launched within this range include high sensitivity Atto® dyes and Cy® dyes. Innova has also released a rapid biotin conjugation kit which allows for extremely quick protein biotinylation. Despite the short incubation time, the conjugation reaction is sufficient to achieve conjugates with performance characteristics identical to, or better than, those prepared with laborious multistep conjugation procedures.

Lightning-Link is an innovative technology that enables direct labelling of antibodies, proteins, peptides or other biomolecules for use in R&D applications, drug discovery and the development of diagnostic kits. The procedure is easy to use, involves only 30 seconds of hands-on time, and no spin or separation steps are required. In addition, by circumventing the desalting or dialysis steps that commonly interrupt traditional protein labelling procedures, Lightning-Link® Rapid technology can be used to label small quantities of antibody with 100% recovery.

Dr Nick Gee, CEO at Innova, said: “The launch of the Lightning-Link kits completes the development of our Rapid conjugation range, and follows on from the success of the original kits, which had a much longer reaction time. This latest product introduction underlines Lightning-Link as one of the world’s leading bioconjugation technologies, offering easy-to-use labelling that provides excellent results with minimal hands on time and 100% yield.”